Pages that link to "Q50863928"
Jump to navigation
Jump to search
The following pages link to Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis. (Q50863928):
Displaying 10 items.
- Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain (Q34140692) (← links)
- Impaired Cellular Immunity in the Murine Neural Crest Conditional Deletion of Endothelin Receptor-B Model of Hirschsprung's Disease (Q35660153) (← links)
- Enhanced expressions of endothelin-converting enzyme and endothelin receptors in human colonic tissues of Crohn's disease (Q36492932) (← links)
- Effects of the endothelin-converting enzyme inhibitor SM-19712 in a mouse model of dextran sodium sulfate-induced colitis (Q37229715) (← links)
- Bosentan, an endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of inflammatory bowel disease (Q46641499) (← links)
- Potential role for ET-2 acting through ETA receptors in experimental colitis in mice. (Q51364946) (← links)
- The vasculitis in IBD is associated with the degree of inflammation (Q51780457) (← links)
- Endothelin-1 receptor antagonist (LU-135252) improves the microcirculation and course of TNBS colitis in rats. (Q52931543) (← links)
- Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice. (Q53394023) (← links)
- Endothelin and vascular remodelling in colitis pathogenesis--appendicitis and appendectomy limit colitis by suppressing endothelin pathways. (Q54196198) (← links)